ProMetic raises $30 million

Canada's ProMetic Life Sciences has raised $30 million in debt financing from Structured Alpha LP, an affiliate of Peter J. Thomson's investment firm, Thomvest Asset Management. Thomson's investment firm has now invested $60 million in ProMetic. The biotech offers a range of services, including large-scale purification of biologics, drug development, proteomics and the elimination of pathogens. Release

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.